Hydrogen and methane provide complementary signals because they arise from different microbial activities. Fermenting intestinal microorganisms generate hydrogen, whereas methanogenic archaea use hydrogen and carbon dioxide to produce methane. Measuring both gases can therefore reveal fermentation patterns that a hydrogen-only assessment might not capture, supporting evaluation of abnormal gastrointestinal activity.
After ingestion, the standardized carbohydrate substrate supplies material for intestinal microbes to ferment. Glucose or lactulose may be used, and timed breath measurements track how gas concentrations change afterward. The resulting pattern is interpreted in relation to transit, since gas appearing over time can provide information relevant to intestinal movement and fermentation.
Microbial conversion can alter the gases detected in the breath: methanogenic archaea consume hydrogen together with carbon dioxide and generate methane. Consequently, methane is not simply an additional symptom marker; it reflects a different microbial process. Considering both concentrations helps clinicians assess the overall fermentation pattern rather than relying on one gas alone.
Individual readings are less informative when separated from their sampling sequence. Hydrogen methane testing uses timed breath samples to follow changes in gas concentration after the carbohydrate challenge. Interpreters consider that sequence alongside symptoms and transit-related concerns, because the pattern over time contributes to diagnostic assessment rather than serving as an isolated measurement.
Testing begins with ingestion of a standardized carbohydrate substrate, such as glucose or lactulose. Breath samples are then collected at planned time points and analyzed for hydrogen and methane concentrations. The process is noninvasive, and its value depends on obtaining interpretable changes across the sampling period while accounting for relevant preparation requirements.
It may support assessment when gastrointestinal symptoms suggest abnormal fermentation or altered intestinal transit. The overview identifies bloating, abdominal pain, diarrhea, and constipation as relevant clinical contexts, and names small intestinal bacterial overgrowth and intestinal methanogen overgrowth as key conditions under evaluation. Results can help guide further diagnostic assessment rather than replace clinical judgment.